Theratechnologies

$2.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-3.39%) Today
+$0.01 (+0.44%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell THTX and other stocks, options, and ETFs commission-free!

About THTX

Theratechnologies Inc. Common Shares, also called Theratechnologies, is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada. The listed name for THTX is Theratechnologies Inc. Common Shares.

CEO
Paul Lévesque
Employees
112
Headquarters
Montréal, Québec
Founded
1993
Market Cap
175.59M
Price-Earnings Ratio
Dividend Yield
Average Volume
82.73K
High Today
$2.34
Low Today
$2.17
Open Price
$2.30
Volume
162.13K
52 Week High
$3.32
52 Week Low
$1.33

Collections

THTX Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Jan 18, Pre-Market

You May Also Like